Literature DB >> 136607

Products of the major histocompatibility complex and their relationship to the immune response.

A Munro, S Bright.   

Abstract

The genes of the major histocompatibility complex were first known for the part they played in transplant rejection. Recently, however, it has become clear that the products of that region have an important part to play in the control of the immune response, through their effects both on cooperative and on aggressive interactions between cells. It is now possible to guess at the mechanisms which may underly the association of some major histocompatibility antigens with disease.

Mesh:

Substances:

Year:  1976        PMID: 136607     DOI: 10.1038/264145a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  6 in total

1.  The presence of HLA-DR antigens on lactating human breast epithelium and milk fat globule membranes.

Authors:  R A Newman; M G Ormerod; M F Greaves
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

2.  Dissociation and exchange of the beta 2-microglobulin subunit of HLA-A and HLA-B antigens.

Authors:  F Hyafil; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer.

Authors:  Zehang Jiang; Zhixian Liu; Mengyuan Li; Cai Chen; Xiaosheng Wang
Journal:  Transl Oncol       Date:  2018-07-27       Impact factor: 4.243

4.  Correlate tumor mutation burden with immune signatures in human cancers.

Authors:  Xiaosheng Wang; Mengyuan Li
Journal:  BMC Immunol       Date:  2019-01-11       Impact factor: 3.615

5.  TP53 Mutations Promote Immunogenic Activity in Breast Cancer.

Authors:  Zhixian Liu; Zehang Jiang; Yingsheng Gao; Lirui Wang; Cai Chen; Xiaosheng Wang
Journal:  J Oncol       Date:  2019-06-02       Impact factor: 4.375

6.  Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer.

Authors:  Haoyu Lyu; Mengyuan Li; Zehang Jiang; Zhixian Liu; Xiaosheng Wang
Journal:  Comput Struct Biotechnol J       Date:  2019-07-26       Impact factor: 7.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.